1H3 — Clearbridge Health Share Price
0.000.00%
Last trade - 00:00- SG$5.58m
- SG$12.95m
- SG$11.49m
- 13
- 56
- 17
- 14
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.74 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 8.97 | ||
| Price to Sales | 0.49 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -300.65% | ||
| Return on Equity | -135.61% | ||
| Operating Margin | -294.55% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 21.53 | 36.26 | 11.44 | 16.41 | 11.49 | n/a | n/a | 13.37% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clearbridge Health Limited is a Singapore-based investment holding company. The Company is engaged in integrated healthcare and medical services. Its segments include Strategic investments, Medical clinics/centres, Corporate segment, and Investments. The Strategic investment segment is engaged in investments in identified early-stage biotechnology and information security companies. The Medical clinics/centres segment is engaged in the provision of general medical, dental, and clinical services. The Corporate segment involves the corporate functions. The Investment segment is in investments in various entities in the global healthcare sector. The medical services include general medical services and specialist services. The general medical services include general health services, imaging services, and vaccinations. The specialist services include aesthetics services and dental and orthodontics services.
Directors
- Johnson Chen NEC (45)
- Jeremy Yee CEO (48)
- Liau Yen Liau COO (42)
- Fexlicia Lee CTR (33)
- Simon Hoo OTH (41)
- Sim Ving Lim SEC
- Andrew Lord LED (58)
- Mark Ryan IND (50)
- Soon Liang Tan IND (47)
- How Soon Mah NID (47)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- January 19th, 2010
- Public Since
- December 18th, 2017
- No. of Employees
- 115
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 1,859,224,056
- Address
- 37 Jalan Pemimpin, #08-05 Mapex, 577177
- Web
- https://www.clearbridgehealth.com/
- Phone
- +65 62510136
- Auditors
- Ernst & Young Accountants LLP
Upcoming Events for 1H3
Similar to 1H3
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Beverly JCG
Singapore Exchange Securities Trading Ltd
FAQ
What is the Clearbridge Health share price?
As of Today at 19:00 UTC, shares in Clearbridge Health are trading at SG$0.00. This share price information is delayed by 15 minutes.
How has the Clearbridge Health share price performed this year?
Shares in Clearbridge Health last closed at SG$0.00 and the price had moved by -61.43% over the past 365 days. In terms of relative price strength the Clearbridge Health share price has underperformed the FTSE Developed Asia Pacific Index by -60.8% over the past year.
What are the analyst and broker recommendations for Clearbridge Health?
The overall consensus recommendation for Clearbridge Health is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Clearbridge Health dividend yield?
Clearbridge Health does not currently pay a dividend.
Does Clearbridge Health pay a dividend?
Clearbridge Health does not currently pay a dividend.
When does Clearbridge Health next pay dividends?
Clearbridge Health does not currently pay a dividend.
How do I buy Clearbridge Health shares?
To buy shares in Clearbridge Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Clearbridge Health?
As of the previous close price of SG$0.00, shares in Clearbridge Health had a market capitalisation of SG$5.58m.
Where are Clearbridge Health shares listed?
Here are the trading details for Clearbridge Health:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: 1H3
What kind of share is Clearbridge Health?
Based on an overall assessment of its quality, value and momentum Clearbridge Health is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Clearbridge Health share price forecast for 2025?
The analyst consensus target price for shares in Clearbridge Health is SG$0.26. That is 8566.67% above the last closing price of SG$0.00.
Analysts covering Clearbridge Health currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Clearbridge Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clearbridge Health. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -34.62%.
As of the last closing price of SG$0.00, shares in Clearbridge Health were trading -44.09% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Clearbridge Health PE Ratio?
The Clearbridge Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Clearbridge Health?
Clearbridge Health's management team is headed by:
- Johnson Chen - NEC
- Jeremy Yee - CEO
- Liau Yen Liau - COO
- Fexlicia Lee - CTR
- Simon Hoo - OTH
- Sim Ving Lim - SEC
- Andrew Lord - LED
- Mark Ryan - IND
- Soon Liang Tan - IND
- How Soon Mah - NID